Optimization of protein expression systems for modern drug discovery

Expert Review of Proteomics

Volumn 4, Issue 1, 2007, Pages 67-78

  Forstner, Michael ^a   Leder, Lukas ^a   Mayr, Lorenz M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Automation; Baculovirus; Cell free transcription; Cell free translation; Escherichia coli; Mammalian; Recombinant protein expression

Indexed keywords

BACTERIAL PROTEIN; CELL PROTEIN; RECOMBINANT PROTEIN; VIRUS PROTEIN;

BACULOVIRUS; BIOTECHNOLOGY; CELL FREE SYSTEM; DATA BASE; EUKARYOTIC CELL; EXPERIMENTAL STUDY; GENE OVEREXPRESSION; GENE TECHNOLOGY; GENOMICS; INSECT CELL; MAMMAL CELL; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; ROBOTICS;

CELL-FREE SYSTEM; CLONING, MOLECULAR; DRUG EVALUATION, PRECLINICAL; EUKARYOTIC CELLS; PROKARYOTIC CELLS; PROTEIN BIOSYNTHESIS; ROBOTICS;

ESCHERICHIA COLI; EUKARYOTA; MAMMALIA;

EID: 33846894709     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.4.1.67     Document Type: Review

References (77)

1. McPherson A. Protein crystallization in the structural genomics era. J. Struct. Funct. Genomics 5(1-2), 3-12 (2004).
2. Mayr LM. Tackling the chemo-genomic space by novel screening technologies: monograph of ESRF Workshop 58. In: Chemical Genomics: Small Molecule Probes to Study Cellular Function. Jaroch S, Weinmann H (Eds.), Springer Verlag, Weinheim, Germany, 111-173 (2006).
3. Christendat D, Yee A, Dharamsi A et al. Structural proteomics of an archaeon. Nature Struct. Biol. 7, 903-909 (2000).
4. Roodveldt C, Aharoni A, Tawfik DS. Directed evolution of proteins for heterologous expression and stability. Curr. Opin. Struct. Biol. 15, 50-56 (2005).
5. Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 60, 523-533 (2003).
6. Butt TR, Edavettal SC, Hall JP, Mattern MR. SUMO fusion technology for difficult-to-express proteins. Protein Expr. Purif. 43, 1-9 (2005).
7. Sorensen HP, Sperling-Petersen HU, Mortensen KK. A favorable solubility partner for the recombinant expression of streptavidin. Protein Expr. Purif. 32, 252-259 (2003).
8. Kohli BM, Ostermeier C. A rubredoxin based system for screening of protein expression conditions and on-line monitoring of the purification process. Protein Expr. Purif. 28, 362-367 (2003).
9. Liu Y, Zhao TJ, Yan YB, Zhou HM. Increase of soluble expression in Escherichia coli cytoplasm by a protein disulfide isomerase gene fusion system. Protein Expr. Purif. 44, 155-161 (2005).
10. Chatterjee DK, Esposito D. Enhanced soluble protein expression using two new fusion tags. Protein Expr. Purif. 46, 122-129 (2006). • New fusion tags designed for improvement of soluble expression of recombinant proteins in Escherichia coli.
11. Hammarström M, Hellgren N, Van der Berg S et al. Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli. Prot. Sci. 11, 313-321 (2002).
12. Shih YP, Kung WM, Chen JC et al. High-throughput screening of soluble recombinant proteins Prot. Sci. 11, 1714-1719 (2002).
13. Davis GD, Elisee C, Newham DM, Harrison RG. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotech. Bioeng. 65, 382-388 (1999).
14. Dyson MR, Shadbolt PS, Vincent KJ et al. Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression. BMC Biotechnology 4, 32 (2004).
15. Nallamsetty S, Waugh DS. Solubility-enhancing protein MBP and NusA play a passive role in the folding of their fusion partner. Protein Expr. Purif. 45, 175-182 (2006).
16. Bach H, Mazor Y, Shaky S et al. Escherichia coli maltose binding protein as a molecular chaperone for recombinant intracellular single-chain antibodies. J. Mol. Biol. 312, 79-93 (2001).
17. Arnau J, Lauritzen C, Petersen GE, Pedersen J. Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. Protein Expr. Purif. 48, 1-13 (2006).
18. Qing G, Ma L-C, Khorchid A et al. Cold-shock induced high-yield expression protein production in Escherichia coli. Nat. Biotechnol. 22, 877-882 (2004).
19. Nishihiara K, Kanemori M, Kitagawa M et al. Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisted refolding of an allergen from Japanese cedar pollen, Cryi2, in Escherichia coli. Appl. Environ. Microbiol. 64, 1694-1699 (1999).
20. Xu Y, Weng CL, Narayanan N et al. Chaperone-mediated folding and maturation of the penicillin acylase precursor in the cytoplasm of Escherichia coli. Appl. Environ. Microbiol. 71, 6247-6253 (2005).
21. Sung-Gun K, Dae-Hyuk K, Dae-Hee L et al. Coexpression of folding accessory proteins for production of active cyclodextrin glycosyltransferase of Bacillus macerans in recombinant Escherichia coli. Protein Expr. Purif. 41, 426-432 (2005).
22. Ferrer M, Chernikova TN, Yakimov MM et al. Chaperonins govern growth of Escherichia coli at low temperatures. Nat. Biotechnol. 21, 1266-1267 (2003).
23. Strocchi M, Ferrer M, Timmis KN, Golyshin PN. Low temperature-induced systems failure in Escherichia coli: insights from rescue by cold-adapted chaperones. Proteomics 6, 193-206 (2006). • The crucial role of the cold-shock Cpn60/10 chaperone for successful growth of E. coli at low temperatures is elucidated.
24. Braun P, Ju Y, Halleck A et al. Proteome-scale purification of human proteins from bacteria. Proc. Natl Acad. Sci. USA 99, 2654-2659 (2002).
25. Knaust RKC, Nordlund P. Screening for soluble expression of recombinant proteins in a 96-well format. Anal. Biochem. 297, 79-85 (2001).
26. Scheich C, Leitner D, Sievert V et al. Fast identification of folded human protein domains expressed in E. coli suitable for structural analysis. BMC Struct. Biol. 4, 4 (2004).
27. Lin CT, Moore PA, Auberry DL et al. Automated purification of recombinant proteins: combining high-throughput with high yield. Protein Expr. Purif. 47, 16-24 (2006).
28. Tobbell DA, Middleton BJ, Raines S et al. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens. Protein Expr. Purif. 24, 242-252 (2002).
29. Vincentelli R, Canaan S, Campanacci V et al. High-throughput automated refolding screening of inclusion bodies. Prot. Sci. 22, 2782-2792 (2004).
30. Willis MS, Hogan JK, Prabhakar P et al. Investigation of protein refolding using a fractional factorial screen: a study of reagent effects and interactions. Prot. Sci. 14, 1818-1826 (2005).
31. Altamirano MM, Consuelo G, Possani LD, Fersht AR. Oxidative refolding chromatography of the scorpion toxin Cn5. Nat. Biotechnol. 17, 187-191 (1999).
32. Gao YG, Guan YX, Yao SJ, Cho MG. On-column refolding of recombinant human interferon-γ with an immobilized chaperone fragment. Biotechn. Prog. 19, 915-920 (2003).
33. Schoner BE, Bramlett KS, Guo H, Burris TP. Reconstitution of functional nuclear receptor proteins using high pressure refolding. Mol. Gen. Metabol. 84, 318-322 (2005).
34. Lee SH, Carpenter JF, Chang BS et al. Effects of solutes on solubilization and refolding of proteins from inclusion bodies with high hydrostatic pressure. Prot. Sci. 15, 304-313 (2006).
35. Ikonomou L, Schneider YJ, Agathos SN. Insect cell culture for industrial production of recombinant proteins. Appl. Microbiol. Biotechnol. 62, 1-20 (2003).
36. Philipps B, Forstner M, Mayr LM. Baculovirus expression system for magnetic sorting of infected cells and enhanced titer determination. Biotechniques 36, 80-83 (2004).
37. Philipps B, Rotmann D, Wicki M et al. Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells. Protein Expr. Purif. 42, 211-218 (2005). •• Description of an optimized baculovirus vector and expression methodology that has changed the way recombinant proteins are produced at Novartis International AG (Basel, Switzerland).
38. Chen YJ, Chen WS, Wu TY. Development of a bicistronic baculovirus expression vector by the Rhopalosiphum padi virus 5′ internal ribosome entry site. Biochem. Biophys. Res. Commun. 335, 616-623 (2005).
39. Berger I, Fitzgerald DJ, Richmond TJ. Baculovirus expression system for heterologous multiprotein complexes. Nat. Biotechnol. 22, 1583-1587 (2004).
40. Jarvis DL. Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production. Virology 310, 1-7 (2003).
41. Philipps B, Forstner M, Mayr LM. A baculovirus expression vector system for simultaneous protein expression in insect and mammalian cells. Biotechnol. Prog. 21, 708-711 (2005).
42. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23, 567-575 (2005). •• Excellent paper illustrating the capabilities of baculovirus transduction of mammalian cells.
43. McCall EJ, Danielsson A, Hardern IM et al. Improvements to the throughput of recombinant protein expression in the baculovirus/insect cell system. Protein Expr. Purif. 42, 29-36 (2005).
44. Hunt I. From gene to protein: a review of new and enabling technologies for multi-parallel protein expression. Protein Expr. Purif. 40, 1-22 (2005). • Very good overview of technological developments.
45. Bahia D, Cheung R, Buchs M et al. Optimisation of insect cell growth in deep-well blocks: development of a high-throughput insect cell expression screen. Protein Expr. Purif. 39, 61-70 (2005).
46. Massie B, Dionne J, Lamarche N et al. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology (NY) 13, 602-608 (1995).
47. Garnier A, Cote J, Nadeau I et al. Scale up of the adenovirus expression system for the production of recombinant protein in human 293S cells. Cytotechnology 15, 145-155 (1994).
48. Pialoux G, Excler JL, Riviere Y et al. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Res. Hum. Retroviruses 11, 373-381 (1995).
49. Falkner FG, Turecek PL, MacGillivray RT et al. High level expression of active human prothrombin in a vaccinia virus expression system. Thromb. Haemost. 68, 119-124 (1992).
50. Liljestrom P, Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 9, 1356-1361 (1991).
51. Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim. Biophys. Acta 1610, 90-96 (2003).
52. Hassaine G, Wagner R, Kempf J et al. Semliki Forest virus vectors for overexpression of 101 G protein-coupled receptors in mammalian host cells. Protein Expr. Purif. 45, 343-351 (2006).
53. Lundstrom K. Semliki Forest virus vectors for large-scale production of recombinant proteins. Methods Mol. Med. 76, 525-543 (2003).
54. Geisse S, Henke M. Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production. J. Struct. Funct. Genomics 6, 165-170 (2005).
55. Al-Fageeh MB, Marchant RJ, Carden MJ, Smales CM. The cold-shock response in cultured mammalian cells: harnessing the response for the improvement of recombinant protein production. Biotechnol. Bioeng. 93, 829-835 (2006).
56. Beer C, Buhr P, Hahn H et al. Gene expression analysis of murine cells producing amphotropic mouse leukaemia virus at a cultivation temperature of 32 and 37 degrees C. J. Gen. Virol. 84, 1677-1686 (2003).
57. Ivanova L, Brandli J, Saudan P, Bachmann MF. Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteins. Biotechniques 39, 209-212 (2005). •• Development of a cold-inducible mammalian expression vector - exciting!
58. Kigawa T, Yabuki T, Yoshida Y et al. Cell-free production and stable-isotope labeling of milligram quantities of proteins. FEBS Lett. 442, 15-19 (1999).
59. Yokoyama S. Protein expression systems for structural genomics and proteomics. Curr. Opin. Chem. Biol. 7, 39-43 (2003).
60. Yee A, Chang X, Pineda-Lucena A et al. An NMR approach to structural proteomics. Proc. Natl Acad. Sci. USA 99, 1825-1830 (2002).
61. Guignard L, Ozawa K, Pursglove SE et al. NMR analysis of in vitro-synthesized proteins without purification: a high-throughput approach. FEBS Lett. 524, 159-162 (2002).
62. Elbaz Y, Steiner-Mordoch S, Danieli T, Schuldiner S. In vitro synthesis of fully functional EmrE, a multidrug transporter, and study of its oligomeric state. Proc. Natl Acad. Sci. USA 101, 1519-1524 (2004).
63. Hendrickson WA, Horton JR, LeMaster DM. Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J. 9, 1665-1672 (1990).
64. Kigawa T, Yamaguchi-Nunokawa E, Kodama K et al. Selenomethionine incorporation into a protein by cell-free synthesis. J. Struct. Funct. Genomics 2, 29-35 (2002).
65. Shimizu Y, Inoue A, Tomari Y et al. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19, 751-755 (2001).
66. He M, Taussig MJ. DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. J. Immunol. Methods 274, 265-270 (2003).
67. Jiang X, Ookubo Y, Fujii I et al. Expression of Fab fragment of catalytic antibody 6D9 in an Escherichia coli in vitro coupled transcription/translation system. FEBS Lett. 514, 290-294 (2002).
68. Sawasaki T, Ogasawara T, Morishita R, Endo Y. A cell-free protein synthesis system for high-throughput proteomics. Proc. Natl Acad. Sci. USA 99, 14652-14657 (2002).
69. Tymms MJ (Ed.) In vitro transcription and translation protocols. In: Methods in Molecular Biology. Vol. 37. Humana Press, NJ, USA (1995).
70. Endo Y, Sawasaki T. High-throughput, genome-scale protein production method based on the wheat germ cell-free expression system. J. Struct. Funct. Genomics 5, 45-57 (2004).
71. Tarui H, Murata M, Tani I et al. Establishment and characterization of cell-free translation/glycosylation in insect cell (Spodoptera frugiperda 21) extract prepared with high pressure treatment. Appl. Microbiol. Biotechnol. 55, 446-453 (2001).
72. Jackson AM, Boutell J, Cooley N, He M. Cell-free protein synthesis for proteomics. Brief Funct. Genomic. Proteomic. 2, 308-319 (2004).
73. Davis BG. Biochemistry. Mimicking posttranslational modifications of proteins. Science 303, 480-482 (2004).
74. Katzen F, Chang G, Kudlicki W. The past, present and future of cell-free protein synthesis. Trends Biotechnol. 23, 150-156 (2005). • Excellent overview of cell-free transcription/translation.
75. Acton TB, Gunsalus KC, Xiao R et al. Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol. 394, 210-243 (2005).
76. Invitrogen Corp. www.invitrogen.com
77. EMD Biosciences, Inc. www.emdbiosciences.com